USPTO serial 79342084
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maurine Knutsson
Maurine Knutsson Knutsson IP ABNelinsgatan 14Norrköping, 603 45SWEDEN| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Collagen for medical use; biological implants, namely, biological eye tissue intended for subsequent implantation, biological skin tissue intended for subsequent implantation, biological cardiac tissue intended for subsequent implantation, biological tissue grafts; biological corneal, cardiac, nerve, and skin tissue for implantation; surgical implants comprised of living tissues; biological materials in the nature of biological preparation for the treatment of eye disease for medical purposes; bioengineered materials in the nature of biological eye tissue; bioengineered biological organ tissues for medical, veterinary and pharmaceutical purposes; biological implants comprising biopolymers, namely, collagen, nanocellulose, and living tissue for delivery of stem cells and biological agents; implants comprising living tissue; implants comprising biopolymers, namely, collagen, nanocellulose for guided tissue regeneration; surgical implants biopolymers, namely, collagen, nanocellulose and native tissue, grown from stem cells; implantable materials in the nature of biopolymers, namely, collagen, nanocellulose, and native tissue for use in guided tissue regeneration; natural cell culture media for medical purposes for cultivating human and animal cells such as corneal, and cardiac cells and stem cells | ACTIVE | — |
| 010 | Corneal implants in the form of inlays made of artificial and natural, non-living, materials; corneal microlens for sight correction being implants made of artificial and natural, non-living, materials; corneal shields being surgical implants and contact lenses made of artificial and natural, non-living, materials; therapeutic contact lenses, drug-eluting contact lenses, bandage contact lenses, corneal implants made of artificial and natural, non-living, materials; corneal implants for sight correction made of artificial and natural, non-living, materials; intra-corneal implants made of artificial and natural, non-living, materials; intra-ocular implants made of artificial and natural, non-living, materials; ocular implants made of artificial and natural, non-living, materials; medical implants made of artificial and natural, non-living, materials; biodegradable implants for eye, skin, and heart applications, made of artificial and natural, non-living, materials; prosthetic implants for eye, skin, and heart applications, made of artificial and natural, non-living, materials; artificial implants for eye, skin, and heart applications, made of artificial and natural, non-living, materials for delivery of cells, stem cells, drugs, genes, and proteins | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 7, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 16, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 25, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 25, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 20, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 20, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 20, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 4, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 4, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 15, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 6, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 27, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 24, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 24, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 24, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 15, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 15, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 20, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 19, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 14, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 10, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 9, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |